Role of adding Isosorbide-5-Mononitrate to misoprostol in Induction of the second trimesteric abortion, a randomized controlled trial

A. Yehia, Hala Alansary
{"title":"Role of adding Isosorbide-5-Mononitrate to misoprostol in Induction of the second trimesteric abortion, a randomized controlled trial","authors":"A. Yehia, Hala Alansary","doi":"10.15406/ogij.2020.11.00510","DOIUrl":null,"url":null,"abstract":"Objective: To compare the therapeutic efficacy of prostaglandins when they used alone versus a combination therapy of prostaglandins and a nitric oxide (NO) donor as isosorbide-5-mononitrate to induce cervical ripening and effacement for induction of the second trimester missed abortion and occurrence of complete abortion. Methods: A Randomized clinical trial study in which 160 Second trimester (13-26weeks) missed abortion pregnant women admitted for medical induction of abortion, were randomly divided into two group (80 patients in each). One group received only vaginal Misoprostol and the other group received combined vaginal Misoprostol with Isosorbide-5-mononitrate. To determine the efficacy in form of \" induction abortion interval \": the duration interval between the beginning of the induction and the complete expulsion of the abortus and also the number of the doses of misoprostol needed to complete expulsion and also the adverse events that increased or newly discovered when prostaglandins and a nitric oxide donor used together such as severe bleeding, headache, abdominal pain, pelvic pain, sever hypotension, backache, fever, nausea and vomiting. Results: It is proved in the study that combination between misoprostol and isosorbide mononitrate gives better results regarding cervical consistency improvement, cervical dilatation, effacement, the whole induction time and the number of misoprostol doses needed to complete expulsion when compared to misoprostol alone and also fewer side effects as abdominal pain. Conclusion: Misoprostol is a good cervical ripening agent when used alone but we can get a benefit from combining both misoprostol and NO donor (isosorbide-5- mononitrate) making a synergistic action with fewer side effects.","PeriodicalId":19389,"journal":{"name":"Obstetrics & Gynecology International Journal","volume":"2 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obstetrics & Gynecology International Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15406/ogij.2020.11.00510","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To compare the therapeutic efficacy of prostaglandins when they used alone versus a combination therapy of prostaglandins and a nitric oxide (NO) donor as isosorbide-5-mononitrate to induce cervical ripening and effacement for induction of the second trimester missed abortion and occurrence of complete abortion. Methods: A Randomized clinical trial study in which 160 Second trimester (13-26weeks) missed abortion pregnant women admitted for medical induction of abortion, were randomly divided into two group (80 patients in each). One group received only vaginal Misoprostol and the other group received combined vaginal Misoprostol with Isosorbide-5-mononitrate. To determine the efficacy in form of " induction abortion interval ": the duration interval between the beginning of the induction and the complete expulsion of the abortus and also the number of the doses of misoprostol needed to complete expulsion and also the adverse events that increased or newly discovered when prostaglandins and a nitric oxide donor used together such as severe bleeding, headache, abdominal pain, pelvic pain, sever hypotension, backache, fever, nausea and vomiting. Results: It is proved in the study that combination between misoprostol and isosorbide mononitrate gives better results regarding cervical consistency improvement, cervical dilatation, effacement, the whole induction time and the number of misoprostol doses needed to complete expulsion when compared to misoprostol alone and also fewer side effects as abdominal pain. Conclusion: Misoprostol is a good cervical ripening agent when used alone but we can get a benefit from combining both misoprostol and NO donor (isosorbide-5- mononitrate) making a synergistic action with fewer side effects.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
米索前列醇中添加异山梨酯-5-单硝酸酯在诱导妊娠中期流产中的作用,一项随机对照试验
目的:比较前列腺素单用与与一氧化氮(NO)供体异山梨酯-5-单硝酸酯联合应用诱导宫颈成熟消退诱导妊娠中期漏产和完全流产的疗效。方法:采用随机临床试验方法,将160例中期妊娠(13-26周)漏产孕妇随机分为两组,每组80例。一组仅阴道使用米索前列醇,另一组使用阴道米索前列醇与异山梨酯-5-单硝酸酯联合使用。以“引产间隔”的形式确定其疗效:引产开始至流产完全排出的时间间隔、完成排出所需米索前列醇的剂量以及前列腺素与一氧化氮供体同时使用时增加或新发现的严重出血、头痛、腹痛、盆腔痛、严重低血压、背痛、发热、恶心和呕吐等不良事件。结果:本研究证明,米索前列醇与单硝酸异山梨酯合用在宫颈一致性改善、宫颈扩张、宫颈消退、整个诱导时间、完成排出所需米索前列醇剂量数等方面均优于单用米索前列醇,腹痛等副作用较少。结论:米索前列醇单独使用是一种良好的宫颈成熟剂,但米索前列醇与NO供体(异山梨酯-5-单硝酸酯)联合使用可获得协同作用,副作用小。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Recurrence of stress urinary incontinence in women treated with transobturator suburethral mesh: 9-year follow-up Probiotics and women health: clinical perspective Enabling, predisposing, and reinforcing factors influencing implementation of exclusive breastfeeding among lactating mothers in Limpopo Province, South Africa Delivery in water, experiences in a population of Mexican women in Mexico City Non-gestational primary choriocarcinoma of the ovary. Presentation of a clinical case
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1